Retraction
Metformin exerts anticancer effects through the inhibition of the Sonic hedgehog signaling pathway in breast cancer
Paper Information
Record ID:
42471
Journal:
Publication Date:
May 21, 2015
Retraction Date:
February 03, 2023
(2.8 years years ago)
Subjects:
Institutions:
- Department of Chemotherapy, Cancer Center, Qilu Hospital, Shandong University, Jinan, Shandong 250012, P.R. China
- Department of Human Anatomy and Key Laboratory of Experimental Teratology, Ministry of Education, Shandong University School of Medicine, Jinan, Shandong 250012, P.R. China
- Department of Emergency Medicine, The Fifth People's Hospital, Jinan, Shandong 250022, P.R. China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Spandidos
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.3892/ijmm.2023.5227Additional Notes:
see also: https://pubpeer.com/publications/27416C3CEC60CAA784A8DF324109B7
Citations (61)
61
Total Citations5
Post-Retraction(8.2%)
56
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
4
Within 1 year
0
After 2+ years
574
Days since retraction (latest)
Medium Renewal Blocks Anti-Proliferative Effects of Metformin in Cultured MDA-MB-231 Breast Cancer Cells
Maruša Rajh, Klemen Dolinar, Katarina Miš et al. (5 authors)
PLoS ONE
Open Access
Published: May 2016
18 citations
18 citations
2468 days before retraction
Autocrine Sonic hedgehog signaling promotes gastric cancer proliferation through induction of phospholipase Cγ1 and the ERK1/2 pathway
Ertao Zhai, Jianhui Chen, Chuangqi Chen et al. (8 authors)
Journal of Experimental & Clinical Cancer Research
Open Access
Published: Apr 2016
41 citations
41 citations
2498 days before retraction
Risk-Reducing (Chemopreventive) Agents in Breast Cancer Prevention
Naomi Gronich, Gad Rennert
Springer eBooks
Published: Jan 2016
2590 days before retraction
Metformin may reduce oral cancer risk in patients with type 2 diabetes
Chin‐Hsiao Tseng
Oncotarget
Open Access
Published: Dec 2015
49 citations
49 citations
2606 days before retraction
Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells
Carminia Maria Della Corte, Vincenza Ciaramella, Concetta Di Mauro et al. (14 authors)
Oncotarget
Open Access
Published: Dec 2015
66 citations
66 citations
2611 days before retraction
Metformina: un arma noble para tiempos más civilizados
Christian Omar Ramos-Peñafiel, Adrián Santoyo-Sánchez, Irma Olarte-Carrillo et al. (6 authors)
Medicina Interna de México
Published: Dec 2015
2621 days before retraction
The Potential Role of Hedgehog Signaling in the Luminal/Basal Phenotype of Breast Epithelia and in Breast Cancer Invasion and Metastasis
Arwa Flemban, David Qualtrough
Cancers
Open Access
Published: Sep 2015
36 citations
36 citations
2697 days before retraction
Estado del arte: metformina, cáncer y leucemia
Christian Omar Ramos-Peñafiel, Adrián Santoyo-Sánchez, Irma Olarte-Carrillo et al. (6 authors)
Revista de Hematología
Published: Jul 2015
2752 days before retraction
Novel Holistic Approaches for Overcoming Therapy Resistance in Pancreatic and Colon Cancers
Fazlul H. Sarkar
Medical Principles and Practice
Open Access
Published: Jul 2015
6 citations
6 citations
2752 days before retraction
State of the art: Metformin, cancer and leukemia
Christian Omar ar Ramos-Peñafiel, Adrián Santoyo-Sánchez, Irma Olarte-Carrillo et al. (6 authors)
Revista de Hematología
Published: Jul 2015
2752 days before retraction
Breast Cancer Metabolism and Mitochondrial Activity: The Possibility of Chemoprevention with Metformin
Massimiliano Cazzaniga, Bernardo Bonanni
BioMed Research International
Open Access
Published: Jan 2015
32 citations
32 citations
2955 days before retraction
Quick Stats
Total Citations:
61
Years Since Retraction:
2.8 years
Open Access:
Yes
Last Checked:
Jul 24, 2025